Select therapeutic use:

CHF and arrhythmias:

Indications for BLOCADREN:

In stabilized patients after MI, to reduce mortality and risk of reinfarction.

Adult Dosage:

10mg twice daily.

Children Dosage:

Not recommended.

BLOCADREN Contraindications:

Asthma. Severe COPD. Sinus bradycardia. 2nd- or 3rd-degree AV block. Overt heart failure. Cardiogenic shock.

BLOCADREN Warnings/Precautions:

CHF. Ischemic heart disease. Bronchospastic disease, COPD. Renal or hepatic dysfunction. Diabetes. Hyperthyroidism. Cerebrovascular insufficiency. Surgery. SLE. Avoid abrupt cessation. Pregnancy (Cat.C). Nursing mothers: not recommended.

BLOCADREN Classification:

Beta-blocker.

BLOCADREN Interactions:

Hypotension, bradycardia with catecholamine-depleting drugs. May increase cardiac effects of calcium channel blockers, digitalis. May be potentiated by quinidine. Increased rebound hypertension with clonidine withdrawal. Antagonized by NSAIDs. Adjust antidiabetic medications. May interfere with glaucoma screening tests. May block epinephrine.

Adverse Reactions:

Cardiac failure, bronchospasm, asthenia, bradycardia, dizziness, arrhythmia, heart block, dyspnea, muscle weakness, cold extremities, decreased libido, chest pain, syncope, pruritus.

How Supplied:

Tabs—100

Hypertension:

Indications for BLOCADREN:

Hypertension.

Adult Dosage:

Initially 10mg twice a day. Increase weekly if needed. Usual maintenance: 20–40mg/day; max 60mg/day in 2 divided doses.

Children Dosage:

Not recommended.

BLOCADREN Contraindications:

Asthma. Severe COPD. Sinus bradycardia. 2nd- or 3rd-degree AV block. Overt heart failure. Cardiogenic shock.

BLOCADREN Warnings/Precautions:

CHF. Ischemic heart disease. Bronchospastic disease, COPD. Renal or hepatic dysfunction. Diabetes. Hyperthyroidism. Cerebrovascular insufficiency. Surgery. SLE. Avoid abrupt cessation. Pregnancy (Cat.C). Nursing mothers: not recommended.

BLOCADREN Classification:

Noncardioselective beta-blocker.

BLOCADREN Interactions:

Hypotension, bradycardia with catecholamine-depleting drugs. May increase cardiac effects of calcium channel blockers, digitalis. May be potentiated by quinidine. Increased rebound hypertension with clonidine withdrawal. Antagonized by NSAIDs. Adjust antidiabetic medications. May interfere with glaucoma screening tests. May block epinephrine.

Adverse Reactions:

Cardiac failure, bronchospasm, asthenia, bradycardia, dizziness, arrhythmia, heart block, dyspnea, muscle weakness, cold extremities, decreased libido, chest pain, syncope, pruritus.

How Supplied:

Tabs—100

Migraine and headache:

Indications for BLOCADREN:

Migraine prophylaxis.

Adult Dosage:

Initially 10mg twice a day. Increase weekly if needed; max 30mg daily in 2 divided doses. Evaluate at 6–8 wks.

Children Dosage:

Not recommended.

BLOCADREN Contraindications:

Asthma. Severe COPD. Sinus bradycardia. 2nd- or 3rd-degree AV block. Overt heart failure. Cardiogenic shock.

BLOCADREN Warnings/Precautions:

CHF. Ischemic heart disease. Bronchospastic disease, COPD. Renal or hepatic dysfunction. Diabetes. Hyperthyroidism. Cerebrovascular insufficiency. Surgery. SLE. Avoid abrupt cessation. Pregnancy (Cat.C). Nursing mothers: not recommended.

BLOCADREN Classification:

Noncardioselective beta-blocker.

BLOCADREN Interactions:

Hypotension, bradycardia with catecholamine-depleting drugs. May increase cardiac effects of calcium channel blockers, digitalis. May be potentiated by quinidine. Increased rebound hypertension with clonidine withdrawal. Antagonized by NSAIDs. Adjust antidiabetic medications. May interfere with glaucoma screening tests. May block epinephrine.

Adverse Reactions:

Cardiac failure, bronchospasm, asthenia, bradycardia, dizziness, arrhythmia, heart block, dyspnea, muscle weakness, cold extremities, depression, decreased libido, chest pain, syncope, pruritus.

How Supplied:

Tabs—100